moxifloxacin has been researched along with daptomycin in 9 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (daptomycin) | Trials (daptomycin) | Recent Studies (post-2010) (daptomycin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 2,266 | 75 | 1,407 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buszewski, B; Fuchs, P; Kegler, R; Miekisch, W; Mundkowski, RG; Olszowy, P; Schubert, JK; Szultka, M | 1 |
| Parra-Ruiz, J; Rose, WE; Rybak, MJ; Vidaillac, C | 1 |
| Hartmann, B; Keller, F; Maus, S; Rothermund, L | 1 |
| Li, L; Liu, X; Liu, Y; Qu, Y; Wang, X; Zhao, X | 1 |
| Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA | 1 |
| Buyck, JM; Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Fernandes, P; Rodriguez-Villalobos, H; Siala, W; Tulkens, PM; Van Bambeke, F | 1 |
| El-Najjar, N; Gessner, A; Hösl, J | 1 |
9 other study(ies) available for moxifloxacin and daptomycin
| Article | Year |
|---|---|
Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.
Topics: Acetamides; Anti-Bacterial Agents; Anticoagulants; Aza Compounds; Chromatography, High Pressure Liquid; Daptomycin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Linezolid; Moxifloxacin; Oxazolidinones; Polymers; Pyrroles; Quinolines; Salts; Solid Phase Microextraction | 2010 |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Clarithromycin; Daptomycin; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.
Topics: Anti-Bacterial Agents; Aza Compounds; Daptomycin; Endocarditis, Bacterial; Fibrinogen; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocytopenia; Vancomycin | 2011 |
Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Aza Compounds; Daptomycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Quinolines; Reactive Oxygen Species; Staphylococcus aureus; Thiourea; Time Factors | 2012 |
Effect of pulmonary surfactant on antimicrobial activity in vitro.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline | 2013 |
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Topics: Anti-Bacterial Agents; Ceftazidime; Cells, Cultured; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Guanidines; Humans; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.
Topics: Acenaphthenes; Anti-Bacterial Agents; Azithromycin; Cell Line; Daptomycin; Heterocyclic Compounds, 3-Ring; Humans; Linezolid; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Phagocytes; Staphylococcus aureus; THP-1 Cells; Vancomycin | 2018 |
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Rifampin; Staphylococcus epidermidis | 2018 |
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles | 2018 |